文献速递瘢痕与激光创面修复美容整形

自体脂肪填充通过诱导促再生免疫反应改善症状性真皮瘢痕

Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response.
PubMed 文献 · Aesthet Surg J · 2022-01-01

结果显示,患者与观察者瘢痕评估量表(POSAS)总分从治疗前73.2降至第一次治疗后46.1、第二次治疗后32.3,且瘢痕组织出现T淋巴细胞、肥大细胞和M2巨噬细胞浸润,伴血管化增加、表皮细胞增殖及细胞外基质重塑。

要点

  • 2次间隔3个月的脂肪填充可显著降低症状性瘢痕的POSAS评分
  • 脂肪填充后瘢痕组织出现促再生免疫细胞浸润和血管化增加
  • 表皮增殖恢复至接近正常皮肤,细胞外基质组织趋于正常化

核心结论

  • 自体脂肪填充通过诱导促再生免疫反应、增加血管化、促进表皮增殖和重塑瘢痕细胞外基质,改善真皮瘢痕的临床结局。

研究设计与样本

  • 治疗前后取瘢痕活检,以POSAS为主要结局,并在细胞水平评估瘢痕重塑。

主要发现

  • POSAS总分从治疗前73.2[14.7]分降至第一次治疗后46.1[14.0]分、第二次治疗后32.3[13.2]分。
  • 患者POSAS评分从37.3[8.8]分降至27.2[11.3]分和21.1[11.4]分,观察者POSAS评分从35.9[9.5]分降至18.9[6.0]分和11.3[4.5]分。
  • 每次脂肪填充后,T淋巴细胞、肥大细胞和M2巨噬细胞浸润瘢痕组织,并与血管化增加相关。
  • 瘢痕相关表皮细胞增殖增加至接近正常皮肤水平,细胞外基质组织向正常皮肤方向正常化。

临床怎么用

  • 对于有症状的真皮瘢痕,可考虑间隔3个月行2次自体脂肪填充以改善瘢痕相关症状和外观。
  • 治疗效应可能与促再生免疫反应、血管化和表皮增殖相关,可作为机制解释与患者沟通的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autologous lipofilling is an emerging procedure to treat and possibly reverse dermal scars and to reduce scar-related pain, but its efficacy and mechanisms are poorly understood. OBJECTIVES: The aim of this study was to test the hypothesis that repeated lipografts reverse dermal scars by reinitiation of wound healing. METHODS: In a prospective, non-placebo-controlled clinical study, 27 adult patients with symptomatic scars were given 2 lipofilling treatments at 3-month intervals. As primary outcome, clinical effects were measured with the Patient and Observer Scar Assessment Scale (POSAS). Scar biopsies were taken before and after treatments to assess scar remodeling at a cellular level. RESULTS: Twenty patients completed the study. Patients' scars improved after lipofilling. The total POSAS scores (combined patient and observer scores) decreased from 73.2 [14.7] points (mean [standard deviation]) pretreatment to 46.1 [14.0] and 32.3 [13.2] points after the first and second lipofilling treatment, respectively. Patient POSAS scores decreased from 37.3 [8.8] points to 27.2 [11.3] and 21.1 [11.4] points, whereas observer POSAS scores decreased from 35.9 [9.5] points to 18.9 [6.0] and 11.3 [4.5] points after the first and second treatment, respectively. After each lipofilling treatment, T lymphocytes, mast cells, and M2 macrophages had invaded scar tissue and were associated with increased vascularization. In addition, the scar-associated epidermis showed an increase in epidermal cell proliferation to levels similar to that normal in skin. Moreover, lipofilling treatment caused normalization of the extracellular matrix organization towards that of normal skin. CONCLUSIONS: Autologous lipofilling improves the clinical outcome of dermal scars through the induction of a pro-regenerative immune response, increased vascularization, and epidermal proliferation and remodeling of scar tissue extracellular matrix.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Spiekman M, Francia DL, Mossel DM, et al. Autologous Lipofilling Improves Clinical Outcome in Patients With Symptomatic Dermal Scars Through Induction of a Pro-Regenerative Immune Response. Aesthet Surg J. 2022. PMID: 34270698. doi:10.1093/asj/sjab280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。